US Patent 10457717 Engineered polypeptides
Patent 10457717 was granted and assigned to Denali Therapeutics on October, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10457717 Engineered polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
